Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Professional stress and social support feelings, coping strategies, and burn-out of caregivers in care facilities for dependent elderly people.

Tonna S.

Geriatr Psychol Neuropsychiatr Vieil. 2019 Sep 1;17(3):327-335. doi: 10.1684/pnv.2019.0816.

PMID:
31449051
2.

Correction: Chondrocytic ephrin B2 promotes cartilage destruction by osteoclasts in endochondral ossification.

Tonna S, Poulton IJ, Taykar F, Ho PW, Tonkin B, Crimeen-Irwin B, Tatarczuch L, McGregor NE, Mackie EJ, Martin TJ, Sims NA.

Development. 2017 Feb 1;144(3):530. doi: 10.1242/dev.148460. No abstract available.

3.

Chondrocytic ephrin B2 promotes cartilage destruction by osteoclasts in endochondral ossification.

Tonna S, Poulton IJ, Taykar F, Ho PW, Tonkin B, Crimeen-Irwin B, Tatarczuch L, McGregor NE, Mackie EJ, Martin TJ, Sims NA.

Development. 2016 Feb 15;143(4):648-57. doi: 10.1242/dev.125625. Epub 2016 Jan 11. Erratum in: Development. 2017 Feb 1;144(3):530.

4.

EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis.

Tonna S, Takyar FM, Vrahnas C, Crimeen-Irwin B, Ho PW, Poulton IJ, Brennan HJ, McGregor NE, Allan EH, Nguyen H, Forwood MR, Tatarczuch L, Mackie EJ, Martin TJ, Sims NA.

FASEB J. 2014 Oct;28(10):4482-96. doi: 10.1096/fj.14-254300. Epub 2014 Jun 30. Erratum in: FASEB J. 2017 Mar;31(3):1249.

PMID:
24982128
5.

Talking among ourselves: paracrine control of bone formation within the osteoblast lineage.

Tonna S, Sims NA.

Calcif Tissue Int. 2014 Jan;94(1):35-45. doi: 10.1007/s00223-013-9738-2. Epub 2013 May 22. Review.

PMID:
23695526
6.

EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.

Takyar FM, Tonna S, Ho PW, Crimeen-Irwin B, Baker EK, Martin TJ, Sims NA.

J Bone Miner Res. 2013 Apr;28(4):912-25. doi: 10.1002/jbmr.1820.

7.

Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.

Pirola L, Balcerczyk A, Tothill RW, Haviv I, Kaspi A, Lunke S, Ziemann M, Karagiannis T, Tonna S, Kowalczyk A, Beresford-Smith B, Macintyre G, Kelong M, Hongyu Z, Zhu J, El-Osta A.

Genome Res. 2011 Oct;21(10):1601-15. doi: 10.1101/gr.116095.110. Epub 2011 Sep 2.

8.

A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9.

Genovese G, Tonna SJ, Knob AU, Appel GB, Katz A, Bernhardy AJ, Needham AW, Lazarus R, Pollak MR.

Kidney Int. 2010 Oct;78(7):698-704. doi: 10.1038/ki.2010.251. Epub 2010 Jul 28.

9.

Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms.

Tonna S, El-Osta A, Cooper ME, Tikellis C.

Nat Rev Nephrol. 2010 Jun;6(6):332-41. doi: 10.1038/nrneph.2010.55. Epub 2010 Apr 27. Review.

PMID:
20421885
10.

Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis.

Brown EJ, Schlöndorff JS, Becker DJ, Tsukaguchi H, Tonna SJ, Uscinski AL, Higgs HN, Henderson JM, Pollak MR.

Nat Genet. 2010 Jan;42(1):72-6. doi: 10.1038/ng.505. Epub 2009 Dec 20. Erratum in: Nat Genet. 2010 Apr;42(4):361. Tonna, Stephen J [added].

11.

Invited commentary: defining incident chronic kidney disease in epidemiologic study settings.

Tonna SJ.

Am J Epidemiol. 2009 Aug 15;170(4):425-7. doi: 10.1093/aje/kwp148. Epub 2009 Jun 17.

PMID:
19535544
12.

NPHS2 variation in focal and segmental glomerulosclerosis.

Tonna SJ, Needham A, Polu K, Uscinski A, Appel GB, Falk RJ, Katz A, Al-Waheeb S, Kaplan BS, Jerums G, Savige J, Harmon J, Zhang K, Curhan GC, Pollak MR.

BMC Nephrol. 2008 Sep 29;9:13. doi: 10.1186/1471-2369-9-13.

13.

The R229Q mutation in NPHS2 may predispose to proteinuria in thin-basement-membrane nephropathy.

Tonna S, Wang YY, Wilson D, Rigby L, Tabone T, Cotton R, Savige J.

Pediatr Nephrol. 2008 Dec;23(12):2201-7. doi: 10.1007/s00467-008-0934-7. Epub 2008 Aug 26.

PMID:
18726620
14.

Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factors.

Forman JP, Fisher ND, Pollak MR, Cox DG, Tonna S, Curhan GC.

J Clin Hypertens (Greenwich). 2008 Jun;10(6):459-66.

15.

Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications.

Tong Z, Yang Z, Patel S, Chen H, Gibbs D, Yang X, Hau VS, Kaminoh Y, Harmon J, Pearson E, Buehler J, Chen Y, Yu B, Tinkham NH, Zabriskie NA, Zeng J, Luo L, Sun JK, Prakash M, Hamam RN, Tonna S, Constantine R, Ronquillo CC, Sadda S, Avery RL, Brand JM, London N, Anduze AL, King GL, Bernstein PS, Watkins S; Genetics of Diabetes and Diabetic Complication Study Group, Jorde LB, Li DY, Aiello LP, Pollak MR, Zhang K.

Proc Natl Acad Sci U S A. 2008 May 13;105(19):6998-7003. doi: 10.1073/pnas.0800454105. Epub 2008 May 5.

16.

Functional genetic variation in aminopeptidase A (ENPEP): lack of clear association with focal and segmental glomerulosclerosis (FSGS).

Tonna S, Dandapani SV, Uscinski A, Appel GB, Schlöndorff JS, Zhang K, Denker BM, Pollak MR.

Gene. 2008 Feb 29;410(1):44-52. doi: 10.1016/j.gene.2007.11.014. Epub 2007 Dec 3.

17.

Do mutations in COL4A1 or COL4A2 cause thin basement membrane nephropathy (TBMN)?

Zhang KW, Tonna S, Wang YY, Rana K, Padavarat S, Savige J.

Pediatr Nephrol. 2007 May;22(5):645-51. Epub 2007 Jan 10.

PMID:
17216253
18.

Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.

Rana K, Tonna S, Wang YY, Sin L, Lin T, Shaw E, Mookerjee I, Savige J.

Pediatr Nephrol. 2007 May;22(5):652-7. Epub 2007 Jan 10.

PMID:
17216251
19.

The risks of thin basement membrane nephropathy.

Tonna S, Wang YY, MacGregor D, Sinclair R, Martinello P, Power D, Savige J.

Semin Nephrol. 2005 May;25(3):171-5. Review.

PMID:
15880328
20.

The genetics of thin basement membrane nephropathy.

Rana K, Wang YY, Buzza M, Tonna S, Zhang KW, Lin T, Sin L, Padavarat S, Savige J.

Semin Nephrol. 2005 May;25(3):163-70. Review.

PMID:
15880327
21.

COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN).

Wang YY, Rana K, Tonna S, Lin T, Sin L, Savige J.

Kidney Int. 2004 Mar;65(3):786-90.

22.

Thin basement membrane nephropathy.

Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY.

Kidney Int. 2003 Oct;64(4):1169-78. Review.

Supplemental Content

Support Center